Cargando…

Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

BACKGROUND: Patients with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) run a 10-fold increased risk of developing colorectal cancer (CRC) compared to patients with IBD only. The aim of this study was to perform an extensive screen of known carcinogenic genomic alteration...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Krijger, Manon, Carvalho, Beatriz, Rausch, Christian, Bolijn, Anne S, Delis-van Diemen, Pien M, Tijssen, Marianne, van Engeland, Manon, Mostafavi, Nahid, Bogie, Roel M M, Dekker, Evelien, Masclee, Ad A M, Verheij, Joanne, Meijer, Gerrit A, Ponsioen, Cyriel Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Leading Off
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434447/ https://www.ncbi.nlm.nih.gov/pubmed/35554535 http://dx.doi.org/10.1093/ibd/izac087

Ejemplares similares

Natural History and Risk Stratification of Recurrent Crohn’s Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort Study
por: Joustra, Vincent, et al.
Publicado: (2021)

Lower Impact of Disease on Daily Life and Less Fatigue in Patients With Inflammatory Bowel Disease Following a Lifestyle Intervention
por: Lamers, Carlijn R, et al.
Publicado: (2022)

Sustained Diet-Induced Remission in Pediatric Crohn’s Disease Is Associated With Kynurenine and Serotonin Pathways
por: Ghiboub, Mohammed, et al.
Publicado: (2023)

Interrogating the Gut-Brain Axis in the Context of Inflammatory Bowel Disease: A Translational Approach
por: Collins, Stephen M
Publicado: (2020)

Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier
por: Jelinsky, Scott A, et al.
Publicado: (2022)

Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn’s Disease
por: Olaisen, Maya, et al.
Publicado: (2020)

The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation
por: Park, K T, et al.
Publicado: (2020)

Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy
por: Abreu, Maria T, et al.
Publicado: (2022)

Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study
por: Hanzel, Jurij, et al.
Publicado: (2021)

Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
por: Burgueño, Juan F, et al.
Publicado: (2020)

Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health
por: Katinios, Georgios, et al.
Publicado: (2020)

The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease
por: Jabandziev, Petr, et al.
Publicado: (2020)

Multidimensional Impact of Mediterranean Diet on IBD Patients
por: Chicco, Fabio, et al.
Publicado: (2020)

Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
por: Fang, Xin, et al.
Publicado: (2020)

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease
por: Verstockt, Sare, et al.
Publicado: (2021)

Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission
por: Iacucci, Marietta, et al.
Publicado: (2021)

Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells
por: Estrada, Hannah Q, et al.
Publicado: (2021)

Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study
por: Chen, Grace, et al.
Publicado: (2020)

The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study
por: Holmgren, Johanna, et al.
Publicado: (2022)

Label-Free Characterization and Quantification of Mucosal Inflammation in Common Murine Colitis Models With Multiphoton Imaging
por: Kreiss, Lucas, et al.
Publicado: (2022)

Prediction of Crohn’s Disease Stricturing Phenotype Using a NOD2-derived Genomic Biomarker
por: Ashton, James J, et al.
Publicado: (2022)

Health Care Disparities, Social Determinants of Health, and Emotional Impacts in Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey
por: Odufalu, Florence-Damilola, et al.
Publicado: (2023)

Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation
por: Scott, Frank I, et al.
Publicado: (2022)

Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel disease
por: de Krijger, Manon, et al.
Publicado: (2020)

Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
por: O’Hara, Steven P, et al.
Publicado: (2017)

Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis
por: de Krijger, Manon, et al.
Publicado: (2022)

Primary Sclerosing Cholangitis–Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity
por: Kamp, Eline J.C.A., et al.
Publicado: (2021)

Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in Management
por: Milkiewicz, Piotr, et al.
Publicado: (2020)

Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis
por: Kamp, Eline JCA, et al.
Publicado: (2022)

The Simple Cholestatic Complaints Score is a valid and quick patient‐reported outcome measure in primary sclerosing cholangitis
por: van Munster, Kim N., et al.
Publicado: (2020)

A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
por: de Vries, Elisabeth M, et al.
Publicado: (2018)

Gait Speed and Confidence Levels in Persons Using 1 and 2 Canes While Walking a 4-m Course
por: Lisenby, Marion A.
Publicado: (2017)

Collaborative research in surgery: a rising tide lifts all boats
por: Li, Elizabeth, et al.
Publicado: (2022)

Collaborative research: population-based data and validation are necessary
por: Björck, Martin
Publicado: (2022)

Shared decision-making should be a standard part of surgical care
por: Ubbink, Dirk T
Publicado: (2022)

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
por: Lynch, Kate D., et al.
Publicado: (2020)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Genetic Abnormalities in Biliary Brush Samples for Distinguishing Cholangiocarcinoma from Benign Strictures in Primary Sclerosing Cholangitis
por: Timmer, Margriet R., et al.
Publicado: (2016)

Serum Immunoglobulin G4 and Immunoglobulin G1 for Distinguishing Immunoglobulin G4-Associated Cholangitis From Primary Sclerosing Cholangitis
por: Boonstra, Kirsten, et al.
Publicado: (2014)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_ltnib8of3d968n2d0f7vk3nv2t